Adial Pharmaceuticals, Inc. (ADIL) Ownership
ADIL ownership summary
as of October 17, 2026- Institutions
- 29.9% of shares outstanding
- Insiders
- 7.08% of shares outstanding
- Shares outstanding
- 2.6M
- Float
- 2.1M shares available to trade
- Short interest
- 7.01% 183K shares short
- Days to cover
- 3.79 short interest down 12.7% vs prior month
- Institutions 29.85%
- Insiders 7.08%
- Other investors 63.07%
ADIL top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Jane Street Group LLC | 1.22% | 32K | $112,095 | +32,119 (0.0%) | June 30, 2026 |
| 2 | Citadel Advisors Llc | 1.13% | 30K | $103,119 | +29,547 (0.0%) | June 30, 2026 |
| 3 | StoneX Group Inc | 0.75% | 20K | $68,750 | +19,699 (0.0%) | June 30, 2026 |
| 4 | UBS Group AG | 0.73% | 19K | $66,823 | +18,605 (+3,432.7%) | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 0.47% | 12K | $43,252 | −11,856 (−48.9%) | June 30, 2026 |
| 6 | China Universal Asset Mgmt Co.Ltd | 0.30% | 8,000 | $27,920 | +8,000 (0.0%) | June 30, 2026 |
| 7 | Vanguard Fiduciary Trust Co | 0.22% | 5,879 | $20,518 | — | June 30, 2026 |
| 8 | Vanguard Capital Management, LLC | 0.22% | 5,831 | $20,350 | +5,470 (+1,515.2%) | June 30, 2026 |
| 9 | Manchester Capital Management LLC | 0.07% | 1,923 | $6,711 | — | June 30, 2026 |
| 10 | Tower Research Capital LLC | 0.05% | 1,419 | $4,952 | +63 (+4.6%) | June 30, 2026 |
| 11 | BlackRock Inc | 0.01% | 304 | $1,061 | −806 (−72.6%) | June 30, 2026 |
| 12 | Raffa Wealth Management LLC | <0.01% | 83 | $290 | — | June 30, 2026 |
| 13 | Morgan Stanley - Brokerage Accounts | <0.01% | 50 | $174 | — | June 30, 2026 |
| 14 | SBI Securities Co Ltd | <0.01% | 47 | $164 | — | June 30, 2026 |
| 15 | Wells Fargo & Co | <0.01% | 6 | $21 | — | June 30, 2026 |
| 16 | HARBOUR INVESTMENTS, INC. | <0.01% | 3 | $10 | — | June 30, 2026 |
| 17 | Abound Wealth Management | 0.00% | 1 | $3 | — | June 30, 2026 |
| 18 | Susquehanna International Group, LLP | 0.00% | — | — | −483 (−100.0%) | March 31, 2026 |
| 19 | Caitong International Asset Management Co., Limited. | 0.00% | — | — | −15 (−100.0%) | June 30, 2026 |
| 20 | Northern Trust Corp | 0.00% | — | — | −2,639 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 7 holders added 114K shares and 5 cut 16K.
ADIL top mutual fund and ETF holders
4 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.45% | 12K | $41,053 | −63 (−0.5%) | August 31, 2026 |
| 2 | China Universal Gbl YLBJ QDII CNH | 0.30% | 8,000 | $27,920 | +8,000 (0.0%) | June 30, 2026 |
| 3 | Fidelity Series Total Market Index | 0.08% | 2,110 | $7,364 | +2,110 (0.0%) | August 31, 2026 |
| 4 | Fidelity Total Market Index | 0.01% | 310 | $1,082 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ADIL insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-29 | Kevin Schuyler | Buy | $68.50 | 28 | $1,918 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ADIL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ADIL
Institutional investors own 29.9% of Adial Pharmaceuticals's shares and insiders 7.08%. The largest holder is Jane Street Group LLC with 1.22% of the shares (32K), as of June 30, 2026. Among the top 20 institutions, 7 added shares and 5 reduced their stake in the latest filings. Short interest is 7.01% of the float, or 3.79 days of average trading volume. The share count rose 14,328.6% since 2016.
Related: ADIL analyst forecast, ADIL key metrics. See the ADIL stock overview for the latest quote and news.
ADIL ownership FAQ
Who owns the most Adial Pharmaceuticals stock?
The largest shareholders of Adial Pharmaceuticals are Jane Street Group LLC (1.22%), Citadel Advisors Llc (1.13%), StoneX Group Inc (0.75%), UBS Group AG (0.73%), Geode Capital Management, LLC (0.47%).
What percentage of Adial Pharmaceuticals is owned by institutions?
Institutions hold 29.9% of Adial Pharmaceuticals's shares outstanding; insiders hold 7.08%.
Which funds own Adial Pharmaceuticals?
The largest fund holders of Adial Pharmaceuticals are Fidelity Extended Market Index (0.45%), China Universal Gbl YLBJ QDII CNH (0.30%), Fidelity Series Total Market Index (0.08%), Fidelity Total Market Index (0.01%).
What is Adial Pharmaceuticals's short interest?
183K shares of Adial Pharmaceuticals were sold short, 7.01% of the float; at the average daily volume it would take 3.79 days to cover.
Are insiders buying or selling Adial Pharmaceuticals?
Of the latest 1 reported insider transactions in Adial Pharmaceuticals (since September 29, 2023), 1 were purchases and 0 were sales.
How many shares of Adial Pharmaceuticals are outstanding?
Adial Pharmaceuticals has 2.6M shares outstanding, of which 2.1M are in the public float.